EPI Health, LLC is recalling 37,117 units of Cloderm (clocortolone pivalate) Cream and Minolira (minocycline hydrochloride) extended-release tablets due to quality control failures at the manufacturing facility. This recall includes Cloderm 45g tubes and Minolira tablets in both 105mg and 135mg strengths. The recall was initiated because the manufacturer discontinued the quality program designed to ensure these medications meet the required identity, strength, and purity standards. Consumers should contact their healthcare provider or pharmacist for a refund or guidance on replacement therapy.
The lack of a proper quality assurance program means the manufacturer cannot guarantee the medication contains the correct amount of active ingredient or meets safety standards for purity. This could lead to patients receiving ineffective treatment or unexpected side effects from the medication.
You have 2 options:
Quantity: 18,645 tubes.
Quantity: 12,808 bottles.
Quantity: 5,664 bottles.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.